Evidence map›Paper›PMID 33781960›Full record

ArticleInfectious diseases now2021

Screening around a COVID-19 cluster: Exploring its impact on a local virus outbreak.

Gaëlle Gault, Olivier Monpierre, Gaetane Carion, Patrick Rispal, Hélène Royer, Marie-Edith Lafon, Daniel Habold, Laurent Filleul

Open access · greenAbstract read
In one paragraph

Article in Infectious diseases now, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 64% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Gaëlle GaultSanté publique France (SpFrance), French national public health agency, Nouvelle-Aquitaine regional office, Bordeaux, France. Electronic address: gaelle.gault@santepubliquefrance.fr.
Olivier MonpierreAgence régionale de santé, Regional health agency of Nouvelle-Aquitaine, Bordeaux, France.
Gaetane CarionCentre hospitalier Agen-Nérac, Agen, France.
Patrick RispalCentre hospitalier Agen-Nérac, Agen, France.
Hélène RoyerDepartmental delegation of Lot-et-Garonne, Agence régionale de santé, Agen, France.
Marie-Edith LafonVirology laboratory, Centre hospitalier universitaire de Bordeaux and CNRS UMR5234 Bordeaux University, Bordeaux, France.
Daniel HaboldAgence régionale de santé, Regional health agency of Nouvelle-Aquitaine, Bordeaux, France.
Laurent FilleulSanté publique France (SpFrance), French national public health agency, Nouvelle-Aquitaine regional office, Bordeaux, France.
Agence Régionale de Santé Nouvelle-Aquitaine · FRCentre Hospitalier Agen - Nérac · FRSanté Publique France · FRAgence Régionale de Santé Ile-de-France · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn March 2020, we implemented screening of the contacts of a COVID-19 cluster having occurred in the Lot-et-Garonne department, the first department of the Nouvelle-Aquitaine region to be affected by the active circulation of SARS-CoV-2. We aimed to describe the impact of this screening on the local SARS-CoV-2 outbreak.

methodsAll high-risk contacts, as well as the individuals living in their households, were screened. We detailed the evolution of the number of confirmed COVID-19 cases in the Lot-et-Garonne department and the rest of the Nouvelle-Aquitaine region.

resultsAmong the 89 screened individuals, 10 new cases were confirmed, including 4 asymptomatic persons. In Lot-et-Garonne, the number of confirmed COVID-19 cases immediately decreased after this screening and no epidemic peak occurred, contrary to what was observed in the rest of the region.

conclusionThe early screening of high-risk contacts of COVID-19 cases and members of their household implemented a few days before the first lockdown probably helped to prevent the spread of the virus in the department.

Indexed as

Disease HotspotDisease OutbreaksMass ScreeningCOVID-19FranceHumansCOVID-19ImpactScreening

Identifiers

PMID33781960
PMCPMC7997685
OpenAlexW3145575194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.